🇺🇸 FDA
Pipeline program

SV-BR-1-GM

0001

Phase 2 mab completed

Quick answer

SV-BR-1-GM for Breastcancer is a Phase 2 program (mab) at BriaCell Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
BriaCell Therapeutics
Indication
Breastcancer
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials